fluorodeoxyglucose f18 has been researched along with Thrombocythemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bénard, F; Boileau, R; Boucher, L; Larivée, P; Prévost, S | 1 |
Au, WY; Kwong, YL; Leung, G; Liang, R; Ma, SK; Ooi, GC; Shek, TW | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Thrombocythemia
Article | Year |
---|---|
Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Female; Fluorodeoxyglucose F18; Humans; Hypercalcemia; L-Lactate Dehydrogenase; Lung Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Thrombocytosis | 2006 |
Myeloblastoma (chloroma) in leukemia: case 2. Meningeal granulocytic sarcoma (chloroma) in essential thrombocythemia.
Topics: Antineoplastic Agents, Alkylating; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid; Melphalan; Meningeal Neoplasms; Middle Aged; Neoplasms, Second Primary; Thrombocytosis; Tomography, Emission-Computed | 2000 |